IN DEPTH Covid-19 vaccine mixing: could heterologous boosters improve immunity? Molnupiravir supplies dominate in times of Paxlovid scarcity Supply Chain Cutting the carbon footprint of pharma’s supply chain The pharmaceutical industry must reduce the carbon emissions associated with getting drugs to patients – but how? R&D How AI could unlock the medical potential of psychedelics COVID-19 Uneven supply patterns hinder US rollout of Covid-19 antivirals Covid-19 vaccine mixing: could heterologous boosters improve immunity? Molnupiravir supplies dominate in times of Paxlovid scarcity 02/22/2022 16:35:29
Covid-19 vaccine mixing: could heterologous boosters improve immunity?
Molnupiravir supplies dominate in times of Paxlovid scarcity